JP2025513847A5 - - Google Patents
Info
- Publication number
- JP2025513847A5 JP2025513847A5 JP2024560379A JP2024560379A JP2025513847A5 JP 2025513847 A5 JP2025513847 A5 JP 2025513847A5 JP 2024560379 A JP2024560379 A JP 2024560379A JP 2024560379 A JP2024560379 A JP 2024560379A JP 2025513847 A5 JP2025513847 A5 JP 2025513847A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nucleic acid
- oligonucleotide
- sugar
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263331756P | 2022-04-15 | 2022-04-15 | |
| US63/331,756 | 2022-04-15 | ||
| US202263397320P | 2022-08-11 | 2022-08-11 | |
| US63/397,320 | 2022-08-11 | ||
| US202263411062P | 2022-09-28 | 2022-09-28 | |
| US63/411,062 | 2022-09-28 | ||
| US202363454299P | 2023-03-23 | 2023-03-23 | |
| US63/454,299 | 2023-03-23 | ||
| PCT/US2023/018742 WO2023201095A2 (en) | 2022-04-15 | 2023-04-14 | Oligonucleotide compositions and methods relating thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513847A JP2025513847A (ja) | 2025-04-30 |
| JP2025513847A5 true JP2025513847A5 (cg-RX-API-DMAC7.html) | 2026-04-22 |
Family
ID=88330318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560379A Pending JP2025513847A (ja) | 2022-04-15 | 2023-04-14 | オリゴヌクレオチド組成物及びそれに関連する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250262235A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4507700A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025513847A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250004787A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119317632A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023253657A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3247824A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316178A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024012532A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023201095A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014010250A1 (en) | 2012-07-13 | 2014-01-16 | Chiralgen, Ltd. | Asymmetric auxiliary group |
| EP3094728B1 (en) | 2014-01-16 | 2022-03-09 | Wave Life Sciences Ltd. | Chiral design |
| CN117965536A (zh) | 2015-07-22 | 2024-05-03 | 波涛生命科学有限公司 | 寡核苷酸组合物及其方法 |
| MA46427A (fr) | 2015-10-09 | 2018-08-15 | Wave Life Sciences Ltd | Compositions d'oligonucléotides et procédés associés |
| US11013757B2 (en) | 2016-06-03 | 2021-05-25 | Wave Life Sciences Ltd. | Oligonucleotides, compositions and methods thereof |
| WO2018098264A1 (en) | 2016-11-23 | 2018-05-31 | Wave Life Sciences Ltd. | Compositions and methods for phosphoramidite and oligonucleotide synthesis |
| WO2018237194A1 (en) | 2017-06-21 | 2018-12-27 | Wave Life Sciences Ltd. | Compounds, compositions and methods for synthesis |
| CN111108096A (zh) | 2017-09-18 | 2020-05-05 | 波涛生命科学有限公司 | 寡核苷酸制备技术 |
| JP2021521140A (ja) | 2018-04-12 | 2021-08-26 | ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. | オリゴヌクレオチド組成物及びその使用方法 |
| CA3098624A1 (en) | 2018-05-11 | 2019-11-14 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| AU2020241559A1 (en) | 2019-03-20 | 2021-11-11 | Wave Life Sciences Ltd. | Technologies useful for oligonucleotide preparation |
| MX2021012981A (es) | 2019-04-25 | 2022-01-18 | Wave Life Sciences Ltd | Composiciones de oligonucleotido y metodos de uso de las mismas. |
| EP4784753A2 (en) | 2023-09-27 | 2026-08-05 | Judo Bio Inc. | Slc6a19-targeting modulatory nucleic acid agents |
| AU2024348221A1 (en) | 2023-09-27 | 2026-04-30 | Judo Bio Inc. | Aminoglycosides for delivery of agents to the kidney |
| EP4784172A1 (en) | 2023-09-27 | 2026-08-05 | Judo Bio Inc. | Polymyxins for delivery of agents to the kidney |
| CN117866028A (zh) * | 2024-01-05 | 2024-04-12 | 苏州诺维康生物科技有限公司 | 一种医药中间体及其制备方法 |
| WO2025213136A1 (en) * | 2024-04-05 | 2025-10-09 | Wave Life Sciences Ltd. | Oligonucleotides comprising pn linkages and methods thereof |
| WO2026050243A1 (en) * | 2024-08-26 | 2026-03-05 | Korro Bio, Inc. | Galnac conjugated oligonucleotides for rna editing |
| WO2026096688A1 (en) * | 2024-10-30 | 2026-05-07 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015886A (en) * | 1993-05-24 | 2000-01-18 | Chemgenes Corporation | Oligonucleotide phosphate esters |
-
2023
- 2023-04-14 EP EP23789042.1A patent/EP4507700A2/en active Pending
- 2023-04-14 CA CA3247824A patent/CA3247824A1/en active Pending
- 2023-04-14 IL IL316178A patent/IL316178A/en unknown
- 2023-04-14 CN CN202380044985.5A patent/CN119317632A/zh active Pending
- 2023-04-14 WO PCT/US2023/018742 patent/WO2023201095A2/en not_active Ceased
- 2023-04-14 KR KR1020247037794A patent/KR20250004787A/ko active Pending
- 2023-04-14 JP JP2024560379A patent/JP2025513847A/ja active Pending
- 2023-04-14 US US18/856,553 patent/US20250262235A1/en active Pending
- 2023-04-14 AU AU2023253657A patent/AU2023253657A1/en active Pending
-
2024
- 2024-10-09 MX MX2024012532A patent/MX2024012532A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7625555B2 (ja) | 修飾されたガイドrna | |
| KR102919364B1 (ko) | 유전자 편집을 위한 변형된 가이드 rna | |
| CN108350454B (zh) | 等位基因选择性基因编辑及其用途 | |
| KR100875003B1 (ko) | 누클레오시드의 위치 변형에 의한 올리고누클레오티드 CpG 매개성 면역 자극의 조절 | |
| JP2025516659A5 (cg-RX-API-DMAC7.html) | ||
| US7709617B2 (en) | Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy | |
| JP2023179428A (ja) | メッセンジャーリボ核酸(mRNA)をコードする安定化された核酸 | |
| Wu et al. | Nonenzymic template-directed synthesis on hairpin oligonucleotides. 2. Templates containing cytidine and guanosine residues | |
| ES2585239T3 (es) | Nuevos agonistas sintéticos de TLR9 | |
| JP2021522803A5 (cg-RX-API-DMAC7.html) | ||
| JPH07503613A (ja) | ヌクレオザイム | |
| US20020068709A1 (en) | Therapeutic uses of LNA-modified oligonucleotides | |
| Seela et al. | Palindromic octa-and dodecanucleotides containing 2'-deoxytubercidin: synthesis, hairpin formation, and recognition by the endodeoxyribonuclease EcoRI | |
| US7786089B2 (en) | Immunostimulatory activity of immune modulatory oligonucleotides (IMO™) containing different lengths of palindromic segments | |
| JP2023519274A5 (cg-RX-API-DMAC7.html) | ||
| PT851934E (pt) | Plantas que sintetizam um amido modificado, processo para a sua produção e amido modificado | |
| JP2018537528A (ja) | Nlrp3遺伝子発現を阻害するための組成物およびその使用 | |
| JP2011135877A (ja) | 炎症性症状を含む疾患を治療するための、オリゴヌクレオチド組成物および方法 | |
| JP4787409B2 (ja) | 治療用ホスホジエステラーゼ阻害剤 | |
| JP2006528697A (ja) | イムノマーを化学療法剤と組み合わせて用いる、癌の相乗的処置 | |
| CN110234326A (zh) | 用于抑制因子xii基因表达的组合物和方法 | |
| JP2001512666A5 (cg-RX-API-DMAC7.html) | ||
| Townsend et al. | Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone | |
| CN119451666A (zh) | 用于基因编辑系统的脂质纳米颗粒 | |
| JP3182243B2 (ja) | 一本鎖dna−rnaハイブリッド分子の合成方法 |